Use Of Karanjaphala Churna With Madhu In Keloid

A Randomized Controlled Clinical Trial to Evaluate the Efficacy of Karanjaphala Churna with Madhu in the Management of Utsannamamsa correlated to Hypertrophic Scars and Keloids - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076486

Enrollment

Registered

2024-11-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L910- Hypertrophic scar

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed as utsannamamsa w.s.r. to hypertrophic scar 2. Patients diagnosed as utsannamamsa w.s.r. to keloids. 3.scar area not more than 3 x 3 x 0.5cm. 4.Duration of scar not more than 2 years. 5.Patients of age group 16-60 yrs. 6.Patients irrespective of caste, religion, sex, economical status. 7.Patients who can give the written consent and regular follow up.

Exclusion criteria

Exclusion criteria: 1.Scar area more than 3 x 3 x 0.5 cms. 2.Duration of scar more than 2 year. 3.Warts 4 4.Basal cell carcinoma 5.Squamous cell carcinoma 6.Marjolin ulcer 7.Patients with of HIV infection. 8.Hepatitis B positive (HBsAg) patients. 9.Patients of regional lymphadenopathy.

Design outcomes

Primary

Measure	Time frame
DECREASE IN ITCHING AND TENDERNESS IN KELOID STOPS FUTHER SPREADINGTimepoint: 0TH DAY 7 TH DAY 14 TH DAY 21TH DAY OF APPLICATION	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDR SUJAY SUDHAKAR GHULE

GOVERNMENT AYURVED COLLEGE AND HOSPITAL DHARASHIV

vkkasle@gmail.com9762514160

Outcome results